Binding Affinities of Oxytocin, Vasopressin, and Manning

Binding Affinities of Oxytocin, Vasopressin, and Manning

bioRxiv preprint doi: https://doi.org/10.1101/2020.03.18.995894; this version posted March 18, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Binding affinities of oxytocin, vasopressin, and Manning Compound at oxytocin and V1a 15 receptors in Syrian hamster brains 16 17 Jack H Taylor1,2, Katharine E McCann1,2, Amy P Ross1,2, & H Elliott Albers1,2 18 19 20 1Neuroscience Institute, Georgia State University 21 2Center for Behavioral Neuroscience, Atlanta, Georgia 22 23 24 25 26 27 28 * Corresponding Author 29 Jack H Taylor 30 [email protected] 31 bioRxiv preprint doi: https://doi.org/10.1101/2020.03.18.995894; this version posted March 18, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 32 Author Contributions 33 Conceived the project: KEM, APR, HEA; Conducted pilot experiments: KEM, APR; Conducted 34 experiments: JHT; Data analysis: JHT; Wrote the first draft of the manuscript: JHT; Edited 35 manuscript: KEM, APR, HEA, JHT;Approved final manuscript: KEM, APR, HEA, JHT; 36 Provided funding: HEA 37 38 Acknowledgements 39 The authors would like to thank Alisa Norvelle, M.S. for assistance performing the experimental 40 procedures. This research was supported by NIH grant MH110212 to HEA. 41 42 Conflict of Interest Statement 43 The authors declare no conflict of interest, real or perceived. 44 45 Data Availability Statement 46 Data are available upon reasonable request to the corresponding or senior authors. bioRxiv preprint doi: https://doi.org/10.1101/2020.03.18.995894; this version posted March 18, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 47 ABSTRACT 48 Oxytocin (OT) and arginine vasopressin (AVP), as well as synthetic ligands targeting their 49 receptors (OTR, V1aR), are used in a wide variety of research contexts, but typically their 50 pharmacological properties are determined in only a few species. Syrian hamsters (Mesocricetus 51 auratus) have a long history of use as a behavioral and biomedical model for the study of 52 oxytocin and vasopressin, and more recently, hamsters have been used to investigate behavioral 53 consequences of OT-mediated activation of V1aRs. We sought to determine the binding 54 affinities of OT, AVP, and the selective V1aR antagonist, Manning compound, in OTRs and 55 V1aRs found in hamster brains. We performed saturation binding asays to determine the Kd 56 values for the selective OTR and V1aR radioligands, [125I]OVTA and [125I]LVA in hamster 57 brains. We then performed competition binding assays to determine Ki values for OT, AVP, and 58 Manning compond at both the OTR and V1aR. We found that OT and AVP each had the highest 59 affinity for their canonical receptors (OT-OTR Ki=4.28 nM; AVP-V1ar Ki=4.70 nM), and had 60 the lowest affinity for their non-canonical ligands (OT-V1aR=495.2nM; AVP-OTR Ki=36.1 61 nM). Manning compound had the highest affinity for the V1aR (MC-V1aR Ki=6.87 nM; MC- 62 OTR Ki=213.8 nM), but Manning compound was not as selective for the V1aR as has been 63 reported in rat receptor. When comparing these data to previously published work, we found that 64 the promiscuity of the V1aR in hamsters with respect to oxytocin and vasopressin binding is 65 more similar to the promiscuity of the human V1aR than the rat V1aR receptor. Moreover, the 66 selectivity of oxytocin at hamster receptors is more similar to the selectivity of oxytocin at 67 human receptors than the selectivity of oxytocin at rat receptors. These data highlight the 68 importance of determining the pharmacological properties of behaviorally relevant compounds in 69 diverse models species. 70 71 Key Words: radioligand binding assay, binding affinity, comparative, g protein-coupled receptor, 72 GPCR bioRxiv preprint doi: https://doi.org/10.1101/2020.03.18.995894; this version posted March 18, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 73 The nonapeptide hormones oxytocin (OT) and arginine vasopressin (AVP) and their 74 cognate receptors are widely used in a variety of therapeutic and research contexts, including the 75 study of social behavior. Perhaps due to their roles in modulating a wide variety of social 76 behaviors across mammalian species, OT and AVP have been studied in many species, each with 77 its own behavioral, practical, and ethological considerations 1,2. Moreover, because OT and AVP 78 can bind and activate both the OT receptor (OTR) and the AVP V1a receptor (V1aR) 3, there are 79 dozens of pharmacological compounds that have been developed to selectively target each 80 receptor 4. Despite the widespread study of OT and AVP, the binding affinities of OT and AVP 81 with OTRs and V1aRs have been determined in only a handful of species, with the majority of 82 data limited to human, mouse, and rat receptors 4,5 c.f. 6,7. Comparative studies, in which 83 receptors from multiple species are probed at the same time using exactly the same methodology, 84 show that there are differences in binding affinities (and subsequent activation potencies) even 85 among closely related species 6,7. However, for many of the species that are currently being 86 studied in the context of OT- and AVP-mediated social behavior, the binding affinities at the 87 OTR and V1aR for these peptides, as well as for human-made pharmacological compounds, are 88 not known. 89 The use of diverse animal models, each with its own unique constellation of social 90 behavior, provides a comprehensive yet complex view of the roles of OT and AVP in modulating 91 social behavior 8. A recent comparative analysis shows that, with respect to receptor distribution, 92 OTR and V1aR are quite variable within Rodentia 9. Even among closely related species, there 93 are differences in the OTR and V1aR amino acid sequences, which may translate to differences 94 in ligand binding and signaling. Syrian hamsters are widely used as an animal model in social 95 and biomedical research, and are preferred over other rodent models for many applications, 96 including acute social stress 10,11, circadian rhythms 12,13, reproductive biology 14, sex differences 97 in physiology and behavior 15,16, and infectious diseases 17,18. Hamsters are phylogenetically 98 similar to rats and mice, but display distinct patterns of social behavior and ecology. Despite a 99 long history of use in the context of AVP- and OT-mediated behavior 19,20, the binding affinities 100 at the hamster OTR and V1aR for OT, AVP, and other compounds are not known. This is 101 particularly notable given the potential for behavioral effects of OT acting at the V1aR, and AVP 102 acting at the OTR, as it has been demonstrated that some V1aR-mediated behavior in this species 103 may be via OT, and not AVP 21. Data regarding the binding affinities at the OTR and V1aR for bioRxiv preprint doi: https://doi.org/10.1101/2020.03.18.995894; this version posted March 18, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 104 these peptides, as well as specific agonists and antagonists, may hold explanatory power for in 105 vivo behavioral pharmacology, particularly when AVP and OT are administered in regions in 106 which OTR and V1aR distributions overlap, or when OT and AVP are compared to selective 107 agonists and antagonists. 108 There are a variety of methods used to determine the binding affinity for ligands at g 109 protein-coupled receptors (GPCRs), including radioligand binding assays (RBAs). All RBAs 110 require some type of tissue that has been selectively enriched with the GPCR of interest. Isolated 111 membrane and whole cultured cell preparations are popular methods, but an underused method 112 of determining binding affinity is to carry out an RBA in intact, native tissue that is naturally 113 enriched in the GPCR of interest. This method is simple, provides a cellular context that is as 114 close as possible to in vivo conditions, and many laboratories that study OT- and AVP-mediated 115 social behavior are already equipped to perform these RBAs. Here, we demonstrate the use of an 116 RBA in intact brain sections to determine the binding affinities of the OTR and V1aR in Syrian 117 hamsters. We predicted that if Syrian hamster OTRs and V1aRs function like rat and mouse 118 receptors, then we should obtain binding affinities for the hamster receptors using various 119 compounds that are on the same order of magnitude as have been reported for mouse and rat 120 receptors.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    17 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us